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Introduction {#s1}
============

Childhood brain tumors (CBT) are one of the most common types of cancers in infants and children (behind hematological malignancies) and they account for approximately 20 to 25% of total primary pediatric tumor diagnoses [@pone.0102910-Mueller1]. Their 5-year survival ranges from \>90% to \<10% for various histological subtypes [@pone.0102910-Gajjar1]. A small percentage of these tumors are found in the setting of an identifiable cancer predisposition syndrome, such as neurofibromatosis and melanoma--astrocytoma syndrome [@pone.0102910-Kyritsis1]. However, for most sporadic cases, little is known about the genetic or environmental etiologies.

Cigarette smoking is a major cause of illness and death worldwide. The first phase of Global Adult Tobacco Survey (GATS) reported that a high percentage of men smoke, women begin smoking early, and few successfully quit smoking [@pone.0102910-Giovino1]. It has been hypothesized that some cancers may begin during the early stages of fetal development [@pone.0102910-Klip1]. The exposure to environmental cigarette smoke during pregnancy could lead to DNA mutations and cytogenetic damage and has been shown to act as a transplacental carcinogen in animal studies [@pone.0102910-Anderson1]--[@pone.0102910-Izzotti1]. Increased levels of carcinogenic tobacco-specific nitrosamines could be detected in the urine samples of newborns and the amniotic fluid in early pregnancy of parents who smoked cigarettes during pregnancy [@pone.0102910-Lackmann1]--[@pone.0102910-Milunsky1]. Therefore, parental smoking, which is relatively frequent, may play a role in tumorigenesis of CBT and require further exploration.

However, epidemiological studies on a possible association between parental smoking and the risk of CBT have provided no definitive answers. Overall, the published literature remains inconclusive and inconsistent. For example, a Sweden cohort study and an Italian case--control study suggested a positive association between maternal smoking during pregnancy and the risk of CBT [@pone.0102910-Brooks1], [@pone.0102910-Filippini1], whereas a UK case--control study reported a negative association between them [@pone.0102910-Pang1]. Because of the relatively small number of cases included in the individual studies, we performed a comprehensive meta-analysis to summarize the evidence on whether parental smoking is associated with the risk of CBT.

Methods {#s2}
=======

Search Strategy {#s2a}
---------------

We conducted a literature search (up to January 2014) of Medline and Embase for studies examining the association between parental smoking and the risk of CBT. The search terms were (case-control OR cohort OR epidemiolog\*) AND (cancer OR carcinoma OR neoplasms OR tumor OR tumour) AND (brain OR cerebral OR intracranial OR central nervous system OR glioma OR glioblastoma OR astrocytoma OR craniopharyngioma OR medulloblastoma OR PNET OR ependymomas) AND (smoke OR smoking OR cigarette OR tobacco) for Medline. Similar search terms were used for Embase. We searched articles published in any language and scrutinized references cited by these studies to identify further pertinent studies. This meta-analysis followed the standard criteria for conducting meta-analyses of observational studies and reporting the results [@pone.0102910-Stroup1].

Study selection {#s2b}
---------------

We applied the following inclusion criteria: the study used a cohort or case-control design, the exposure of interest was parental smoking, the outcome was CBT and the investigators provided the minimum information necessary to estimate the relative risk (RR) with 95% confidence intervals (CIs). We excluded animal studies, cross sectional studies, reviews, editorials, commentaries, and letters without sufficient data. If data sets overlapped or were duplicated, the most up-to-date or comprehensive information was included.

Data extraction {#s2c}
---------------

Data were extracted independently by two authors and any disagreements were resolved by consensus. The following information was recorded: the first author\'s last name, year of publication, study location, types of CBT, sample size (cases and controls or cohort size), exposure (smoking levels for each category) assessment method, outcome (CBT) ascertainment, covariates adjusted for in the analysis, and RR estimates with corresponding 95% CIs for each category. If available, we used the RRs that reflected the greatest degree of control for potential confounders.

Statistical analysis {#s2d}
--------------------

RR was used as a measure of the association between parental smoking and the risk of CBT. For case-control studies, the odds ratio (OR) was used as a surrogate measure of the corresponding RR. Because the absolute risk of CBT is low, the OR approximates the RR [@pone.0102910-Greenland1].

Summary RRs (95% CI) were calculated by combining the study-specific RR estimates with the DerSimonian Laird method (random effects model) [@pone.0102910-DerSimonian1]. In the dose--response meta-analysis, we used the method described by Greenland [@pone.0102910-Greenland2] and Orsini [@pone.0102910-Orsini1] to calculate the trend from the correlated estimates for relative risk across smoking categories. The midpoint of the upper and lower boundaries in each category was assigned as the corresponding dose of consumption. If the highest category was open ended, we assumed the width of the interval to be the same as the width in the preceding category. We explored a potential curvilinear relationship between parental smoking and the risk of CBT using restricted cubic splines with three knots at percentiles 25%, 50%, and 75% of the distribution [@pone.0102910-Harrell1]. A *P* value for nonlinearity was calculated by testing the null hypothesis that the coefficient of the second spline was equal to 0.

We calculated the Q statistic (*P*\<0.1 was considered to be indicative of statistically significant heterogeneity) and I^2^ statistic (I^2^\<25% no heterogeneity; I^2^ = 25% to 50% low heterogeneity; I^2^ = 50% to 75% moderate heterogeneity; I^2^\>75% large or extreme heterogeneity) [@pone.0102910-Higgins1] to assess heterogeneity across studies. We also conducted analyses stratified by study design, study location, histological subtype, number of cases and publication year. Influence analysis was performed, in which the summary estimates were computed after the omission of each study in turn. An estimation of potential publication bias was evaluated by Begg\'s adjusted rank correlation test [@pone.0102910-Begg1] and Egger\'s regression asymmetry test [@pone.0102910-Egger1]. All statistical tests were conducted with the STATA software (version 11.0; Stata Corporation, College Station, Texas). *P* values were two sided with a significance level of 0.05.

Results {#s3}
=======

Literature search {#s3a}
-----------------

A flow diagram of our literature search and study selection is shown in [Figure 1](#pone-0102910-g001){ref-type="fig"}. We identified 843 unique citations from Medline and Embase. After excluding studies that did not meet our inclusion criteria, 29 remaining articles appeared to be potentially relevant for this meta-analysis. After evaluating the full texts of these publications, we further excluded 14 articles for the following reasons: duplicate reports from the same study population (n = 8); no data on CBT (n = 3); lack of sufficient data to calculate RR and 95% CIs (n = 2); adult patients included (n = 1). A manual search of references cited by these papers yielded 2 new eligible articles. Therefore, we finally included 17 articles [@pone.0102910-Brooks1]--[@pone.0102910-Pang1], [@pone.0102910-Milne1]--[@pone.0102910-Stjernfeldt1] in the meta-analysis.

![Flowchart of study assessment and selection.](pone.0102910.g001){#pone-0102910-g001}

Study Characteristics {#s3b}
---------------------

The 17 studies were published between 1986 and 2013, involving a total of 5,098 cases. Of these studies, 6 were conducted in North America [@pone.0102910-BarringtonTrimis1], [@pone.0102910-Bunin1]--[@pone.0102910-Howe1], 6 in Europe [@pone.0102910-Brooks1]--[@pone.0102910-Pang1], [@pone.0102910-Plichart1], [@pone.0102910-Schuz1], [@pone.0102910-Stjernfeldt1], 2 in Australia [@pone.0102910-Milne1], [@pone.0102910-Stavrou1], 2 in China [@pone.0102910-Hu1], [@pone.0102910-Ji1] and 1 was multi-centered [@pone.0102910-Filippini2]. 2 studies were cohort studies [@pone.0102910-Brooks1], [@pone.0102910-Stavrou1], and 15 were case-control studies [@pone.0102910-Filippini1], [@pone.0102910-Pang1], [@pone.0102910-Milne1], [@pone.0102910-BarringtonTrimis1], [@pone.0102910-Plichart1]--[@pone.0102910-Stjernfeldt1]. Of the 17 studies, 16 had information on maternal smoking during pregnancy [@pone.0102910-Brooks1]--[@pone.0102910-Pang1], [@pone.0102910-Milne1]--[@pone.0102910-Hu1], [@pone.0102910-Bunin1]--[@pone.0102910-Stjernfeldt1], 7 had data on maternal smoking before pregnancy [@pone.0102910-Filippini1], [@pone.0102910-Pang1], [@pone.0102910-Milne1], [@pone.0102910-Filippini2], [@pone.0102910-Hu1], [@pone.0102910-Gold1], [@pone.0102910-John1], 9 on paternal smoking during pregnancy [@pone.0102910-Milne1], [@pone.0102910-BarringtonTrimis1], [@pone.0102910-Plichart1], [@pone.0102910-Schuz1], [@pone.0102910-Hu1], [@pone.0102910-Bunin1]--[@pone.0102910-John1], [@pone.0102910-Howe1], and 7 on paternal smoking before pregnancy [@pone.0102910-Filippini1], [@pone.0102910-Pang1], [@pone.0102910-Milne1], [@pone.0102910-Filippini2], [@pone.0102910-Hu1], [@pone.0102910-Ji1], [@pone.0102910-Gold1]. 8 studies considered all brain cancers together only [@pone.0102910-Milne1]--[@pone.0102910-Stavrou1], [@pone.0102910-Hu1], [@pone.0102910-Ji1], [@pone.0102910-John1], [@pone.0102910-Howe1], [@pone.0102910-Stjernfeldt1], 1 considered astrocytoma only [@pone.0102910-Kuijten1], and 8 considered several subtypes of CBT and provided separate analyses for these cancer subtypes [@pone.0102910-Brooks1]--[@pone.0102910-Pang1], [@pone.0102910-Plichart1]--[@pone.0102910-Schuz1], [@pone.0102910-Bunin1], [@pone.0102910-Gold1]. In 12 of the 15 incident case-control studies, controls were matched for age and sex [@pone.0102910-Filippini1], [@pone.0102910-Pang1], [@pone.0102910-Milne1], [@pone.0102910-BarringtonTrimis1], [@pone.0102910-Plichart1]--[@pone.0102910-Ji1], [@pone.0102910-Gold1], [@pone.0102910-John1], [@pone.0102910-Howe1]. The numbers of cases and controls or cohort, types of CBT, exposure assessment method, and outcome ascertainment were shown in [Table 1](#pone-0102910-t001){ref-type="table"}.

10.1371/journal.pone.0102910.t001

###### Study characteristics of published cohort and case--control studies on parental smoking and the risk of childhood brain tumors.

![](pone.0102910.t001){#pone-0102910-t001-1}

  First author               Year   Design       Region              Exposure assessment             Outcome ascertainment     Diagnosis criteria   Age        Matched factors           Types of CBT      Cases   Controls or cohort
  ------------------------- ------ -------- ---------------- ------------------------------------ --------------------------- -------------------- ----- --------------------------- -------------------- ------- --------------------
  Barrington-Trimis et al    2013    PCC          USA                In-person interview                SEER registries             ICD-O-1         ≤10       Age, sex, center            Astroglial        97            285
                                                                                                                                                                                             PNET           55    
                                                                                                                                                                                            Others          50    
  Milne et al                2013    PCC       Australia             Mailed questionnaire          Pediatric oncology center           NR           ≤15        Age, sex, state             Gliomas          170           941
                                                                                                                                                                                       Embryonal tumors     71    
                                                                                                                                                                                       Germ cell tumors     20    
                                                                                                                                                                                         Ependymomas        22    
                                                                                                                                                                                            Others          19    
  Stavrou et al              2009   Cohort     Australia           Midwives Data Collection         Central Cancer Registry         ICD-O-3         ≤12              \-                   Total CBT         143        1,045,966
  Plichart et al             2008    PCC         France              Telephone interview           French National Registry         ICD-O-3         ≤15           Age, sex             Embryonal tumors     100          1,681
                                                                                                                                                                                         Ependymomas        33    
                                                                                                                                                                                         Astrocytomas       26    
                                                                                                                                                                                            Others          50    
  Brooks et al               2004   Cohort       Sweden             Swedish Birth Register          Swedish Cancer Register           ICD7          NR               \-                   Ependymoma        51         1,441,942
                                                                                                                                                                                         Astrocytoma        220   
                                                                                                                                                                                       Medulloblastoma      62    
                                                                                                                                                                                            Others          147   
  Pang et al                 2003    PCC           UK                     Interview                Pediatric oncology units         ICD-O-2         ≤15   Age, sex, residence area        Total CBT         635          6,987
  Filippini et al            2002    PCC      Multicenter           Interviewed in person              Cancer registries            ICD-O-2         ≤19           Age, sex             Astroglial tumor     623          2,223
                                                                                                                                                                                             PNET           259   
                                                                                                                                                                                            Others          336   
  Schuz et al                2001    PCC        Germany       Questionnaire, telephone interview   Childhood Cancer Registry           NR           ≤15           Age, sex               Astrocytoma        119          2,458
                                                                                                                                                                                       Medulloblastoma      112   
                                                                                                                                                                                          Ependymoma        50    
                                                                                                                                                                                            Others          185   
  Filippini et al            2000    PCC         Italy               Telephone interview               Hospital records              ICD-9          ≤15   Age, sex, residence area    Astroglial tumours    115           502
                                                                                                                                                                                             PNET           37    
                                                                                                                                                                                            Others          82    
  Hu et al                   2000    HCC         China                    Interview                   Six major hospitals              NR           ≤18   Age, sex, residence area       Astrocytoma        21            246
                                                                                                                                                                                      Medulloepithelioma    13    
                                                                                                                                                                                      Craniopharyngioma     11    
                                                                                                                                                                                            Others          38    
  Ji et al                   1997    PCC         China                 Direct interview                 Cancer Registry              ICD-9          ≤15           Age, sex                Total CBT         107           107
  Bunin et al                1994    PCC     USA and Canada          Telephone interview           Children\'s Cancer Group            NR           ≤6    Age, race, residence area      Astrocytoma        155           321
                                                                                                                                                                                             PNET           166   
  Gold et al                 1993    PCC          USA                Structured interview           SEER program registries            NR           ≤18   Age, sex, mother\'s race       Astrocytoma        152          1,083
                                                                                                                                                                                       Medulloblastoma      60    
                                                                                                                                                                                            Others          126   
  John et al                 1991    PCC          USA               Structured interviews               Cancer Registry                NR           ≤14   Age, sex, residence area        Total CBT         48            196
  Kuitjen et al              1990    PCC          USA                Telephone interview               Tumor registries                NR           ≤15   Age, race, residence area      Astrocytoma        163           163
  Howe et al                 1989    PCC         Canada              In-person interview               Hospital records                NR           ≤18           Age, sex               Astrocytoma        21            138
                                                                                                                                                                                       Medulloblastoma      24    
                                                                                                                                                                                          Ependymoma        10    
                                                                                                                                                                                            Others          19    
  Stjernfeldt et al          1986    PCC         Sweden                       NR                              NR                       NR           ≤16              NR                   Total CBT         43             NR

PCC population based case-control, HCC hospital based case-control, NR not reported.

Quantitative synthesis {#s3c}
----------------------

The pooled RRs between parental smoking and the risk of CBT were not statistically significant and close to unity (RR = 0.96, 95% CI 0.86--1.07 for maternal smoking during pregnancy; RR = 1.09, 95% CI 0.97--1.22 for paternal smoking during pregnancy; RR = 0.93, 95% CI 0.85--1.00 for maternal smoking before pregnancy; RR = 1.09, 95% CI 1.00--1.20 for paternal smoking before pregnancy) ([Figures 2](#pone-0102910-g002){ref-type="fig"} and [S1](#pone.0102910.s002){ref-type="supplementary-material"}).

![Forest plot of maternal smoking during pregnancy and the risk of CBT.](pone.0102910.g002){#pone-0102910-g002}

In the stratified analysis by study region, histological subtype, number of cases, and publication year, no significant associations were observed in any of the categories ([Tables 2](#pone-0102910-t002){ref-type="table"}--[5](#pone-0102910-t005){ref-type="table"}).

10.1371/journal.pone.0102910.t002

###### Results of subgroup analyses of the association between maternal smoking during pregnancy and the risk of childhood brain tumors.
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                                                                                       Heterogeneity test  
  ---------------------- -------------------------------- ------------------- ------- -------------------- -------------------
  Total                     16 (12--14,24--30,32--37)      0.96 (0.86--1.07)                 20.88          28.2 (1.6--60.7)
  Study design                                                                 0.072                       
  Cohort                            2 (12,26)              1.07 (0.72--1.58)                  2.44              59.0 (-)
  Case--control           14 (13,14,24,25,27--30,32--37)   0.92 (0.84--1.00)                 13.41           3.1 (0.0--56.4)
  Geographical region                                                          0.816                       
  North America                   6 (25,32--36)            0.92 (0.76--1.11)                  4.41          0.0 (0.0--74.62)
  Europe                       6 (12--14,27,29,37)         1.03 (0.84--1.27)                 14.35          65.2 (16.3--85.5)
  Australia                         2 (24,26)              0.86 (0.64--1.16)                  0.07               0.0 (-)
  China                               1 (30)               1.20 (0.45--3.23)                   \-                  \-
  Histological subtype                                                          \-                         
  PNET                       8 (12--14,27--29,32,33)       0.89 (0.74--1.06)                  6.58           0.0 (0.0--67.6)
  Astrocytomas              9 (12--14,27--29,32,33,35)     1.05 (0.93--1.18)                  7.69           0.0 (0.0--64.8)
  Ependymomas                    4 (12,14,27,29)           1.09 (0.72--1.66)                  4.22          28.9 (0.0--73.8)
  No of cases                                                                  0.492                       
  ≤ 300                      9 (13,25--27,30,34--37)       1.02 (0.83--1.25)                  9.53          16.1 (0.0--58.1)
  \>300                      7 (12,14,24,28,29,32,33)      0.94 (0.83--1.06)                 10.38          42.2 (0.0--75.7)
  Publication year                                                             0.289                       
  ≤2000                          8 (13,30,32--37)          1.05 (0.88--1.24)                  5.41           0.0 (0.0--67.6)
  \>2000                         8 (12,14,24--29)          0.92 (0.80--1.06)                 14.04          50.1 (0.0--77.7)

\* *P* for heterogeneity of the stratum-specific summary RRs.

10.1371/journal.pone.0102910.t003

###### Results of subgroup analyses of the association between paternal smoking during pregnancy and the risk of childhood brain tumors

![](pone.0102910.t003){#pone-0102910-t003-3}

                                                                                     Heterogeneity test  
  ---------------------- ------------------------------ ------------------- ------- -------------------- ------------------
  Total                   9 (24,25,27,29,30,32--34,36)   1.09 (0.97--1.22)                  2.35          0.0 (0.0--64.8)
  Geographical region                                                        0.892                       
  North America                 5 (25,32--34,36)         1.03 (0.85--1.25)                  1.45          0.0 (0.0--79.2)
  Europe                           2 (27,29)             1.13 (0.96--1.34)                  0.23              0.0 (-)
  Australia                          1 (24)              1.04 (0.74--1.46)                   \-                  \-
  China                              1 (30)              1.17 (0.67--2.04)                   \-                  \-
  Histological subtype                                                        \-                         
  PNET                          4 (27,29,32,33)          1.10 (0.88--1.37)                  0.50          0.0 (0.0--84.7)
  Astrocytomas                  4 (27,29,32,33)          1.13 (0.79--1.61)                  6.27          52.1 (0.0--84.2)
  Ependymomas                      2 (27,29)             1.48 (0.99--2.20)                  0.07              0.0 (-)
  No of cases                                                                0.160                       
  ≤ 300                        5 (25,27,30,34,36)        1.18 (0.96--1.45)                  0.86          0.0 (0.0--79.2)
  \>300                         4 (24,29,32,33)          1.04 (0.91--1.20)                  0.56          0.0 (0.0--84.7)
  Publication year                                                           0.673                       
  ≤2000                         5 (30,32--34,36)         1.05 (0.86--1.28)                  1.63          0.0 (0.0--79.2)
  \>2000                        4 (24,25,27,29)          1.11 (0.96--1.28)                  0.51          0.0 (0.0--84.7)

\* *P* for heterogeneity of the stratum-specific summary RRs.

10.1371/journal.pone.0102910.t004

###### Results of subgroup analyses of the association between maternal smoking before pregnancy and the risk of childhood brain tumors.
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                                                                                 Heterogeneity test  
  ---------------------- -------------------------- ------------------- ------- -------------------- -----------------
  Total                   7 (13,14,24,28,30,33,34)   0.93 (0.85--1.00)                  3.23          0.0 (0.0--70.8)
  Geographical region                                                    0.839                       
  North America                  2 (33,34)           0.89 (0.69--1.15)                  0.00              0.0 (-)
  Europe                         2 (13,14)           1.02 (0.79--1.31)                  2.07             51.6 (-)
  Australia                        1 (24)            0.99 (0.70--1.40)                   \-                 \-
  China                            1 (30)            0.62 (0.10--3.80)                   \-                 \-
  Histological subtype                                                    \-                         
  PNET                          3 (14,28,33)         0.87 (0.69--1.09)                  0.59          0.0 (0.0--89.6)
  Astrocytomas                  3 (14,28,33)         0.91 (0.80--1.03)                  0.04          0.0 (0.0--89.6)
  Ependymomas                      1 (14)            0.73 (0.40--1.35)                   \-                 \-
  No of cases                                                            0.427                       
  ≤300                          3 (13,30,34)         1.14 (0.85--1.53)                  0.84          0.0 (0.0--89.6)
  \>300                       4 (14,24,28,33)        0.91 (0.83--0.99)                  0.31          0.0 (0.0--84.7)
  Publication year                                                       0.962                       
  ≤ 2000                      4 (13,30,33,34)        0.99 (0.82--1.21)                  2.32          0.0 (0.0--84.7)
  \>2000                        3 (14,24,28)         0.91 (0.83--1.00)                  0.28          0.0 (0.0--89.6)

\* *P* for heterogeneity of the stratum-specific summary RRs.

10.1371/journal.pone.0102910.t005

###### Results of subgroup analyses of the association between paternal smoking before pregnancy and the risk of childhood brain tumors.
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                                                                                 Heterogeneity test  
  ---------------------- -------------------------- ------------------- ------- -------------------- -----------------
  Total                   7 (13,14,24,28,30,31,33)   1.09 (1.00--1.20)                  3.29          0.0 (0.0--70.8)
  Geographical region                                                    0.605                       
  North America                    1 (33)            1.08 (0.83--1.41)                   \-                 \-
  Europe                         2 (13,14)           1.08 (0.93--1.25)                  0.53              0.0 (-)
  Australia                        1 (24)            0.99 (0.71--1.38)                   \-                 \-
  China                          2 (30,31)           1.42 (0.90--2.24)                  1.07              6.3 (-)
  Histological subtype                                                    \-                         
  PNET                          3 (14,28,33)         0.94 (0.77--1.16)                  1.50          0.0 (0.0--89.6)
  Astrocytomas                  3 (14,28,33)         1.11 (0.95--1.28)                  1.37          0.0 (0.0--89.6)
  Ependymomas                      1 (14)            1.03 (0.59--1.78)                   \-                 \-
  No of cases                                                            0.130                       
  ≤ 300                         3 (13,30,31)         1.27 (0.98--1.64)                  1.42          0.0 (0.0--89.6)
  \>300                       4 (14,24,28,33)        1.07 (0.97--1.18)                  0.41          0.0 (0.0--84.7)
  Publication year                                                       0.151                       
  ≤ 2000                      4 (13,30,31,33)        1.17 (0.98--1.41)                  2.15          0.0 (0.0--84.7)
  \>2000                        3 (14,24,28)         1.07 (0.96--1.19)                  0.40          0.0 (0.0--89.6)

\* *P* for heterogeneity of the stratum-specific summary RRs.

Dose-response analysis {#s3d}
----------------------

Using a restricted cubic splines model, we did not find a curvilinear association between parental smoking and the risk of CBT (*P* = 0.619, 0.638, 0.924, and 0.749 for non-linearity, respectively). The summary RRs of CBT for an increase of 10 cigarettes per day were 0.98 (95% CI 0.92-1.04; *P* = 0.506 for linear trend), 1.04 (95% CI 0.98-1.11; *P* = 0.196 for linear trend), 0.95 (95% CI 0.89-1.02; *P* = 0.179 for linear trend), and 1.02 (95% CI 0.96-1.07; *P* = 0.598 for linear trend) for maternal smoking during pregnancy, paternal smoking during pregnancy, maternal smoking before pregnancy, and paternal smoking before pregnancy, respectively ([Figures 3](#pone-0102910-g003){ref-type="fig"} and [S2](#pone.0102910.s003){ref-type="supplementary-material"}).

![Dose-response analysis of maternal smoking during pregnancy and the risk of CBT.\
The solid line represents point estimates of association between maternal smoking during pregnancy and CBT risk; dashed lines are 95% CIs. Circles are the dose-specific RR estimates. The relative size of each circle is proportional to the inverse variance of the RR.](pone.0102910.g003){#pone-0102910-g003}

Influence analysis {#s3e}
------------------

In the influence analysis, the influence of each study on the pooled RR was examined by repeating the meta-analysis while omitting each study, one at a time. The study-specific RRs ranged from the lowest values of 0.91 (95% CI 0.83-0.99), 1.06 (95% CI 0.94-1.21), 0.91 (95% CI 0.93-0.99), and 1.08 (95% CI 0.99-1.19) to the highest values of 0.99 (95% CI 0.89-1.10), 1.12 (95% CI 0.98-1.27), 0.96 (95% CI 0.85-1.08), and 1.11 (95% CI 1.00-1.24) for maternal smoking during pregnancy, paternal smoking during pregnancy, maternal smoking before pregnancy, and paternal smoking before pregnancy, respectively ([Figure S3](#pone.0102910.s004){ref-type="supplementary-material"}).

Evaluation of heterogeneity {#s3f}
---------------------------

For maternal smoking during pregnancy, low to moderate between-study heterogeneity was observed for the pooled RR (I^2^ = 28.2%, 95% CI 1.6%-60.7%) and several subgroup results, including cohort studies (I^2^ = 59.0%), studies conducted in Europe (I^2^ = 65.2%, 95% CI 16.3%-85.5%), Ependymomas (I^2^ = 28.9%, 95% CI 0.0%-73.8%), studies of cases \> 300 (I^2^ = 42.2%, 95% CI 0.0%-75.7%), and studies published after 2000 (I^2^ = 50.1%, 95% CI 0.0%-77.7%).

For paternal smoking during pregnancy, there was no obvious heterogeneity between studies, except for Astrocytomas (I^2^ = 52.1%, 95% CI 0.0%-84.2%); for maternal smoking before pregnancy, moderate heterogeneity was observed for studies conducted in Europe (I^2^ = 51.6%); for paternal smoking before pregnancy, no heterogeneity was found in any of the categories.

Publication bias {#s3g}
----------------

There was no evidence of significant publication bias according to the Begg and Egger tests ([Figure 4](#pone-0102910-g004){ref-type="fig"}, Begg, *P* = 0.528, Egger, *P* = 0.790 for maternal smoking during pregnancy; Begg, *P* = 0.348, Egger, *P* = 0.420 for paternal smoking during pregnancy; Begg, *P* = 0.764, Egger, *P* = 0.610 for maternal smoking before pregnancy; Begg, *P* = 0.368, Egger, *P* = 0.189 for paternal smoking before pregnancy).

![Funnel plot of maternal smoking during pregnancy and the risk of CBT.\
The area of each square is proportional to the study\'s weight (inverse of variance).](pone.0102910.g004){#pone-0102910-g004}

Discussion {#s4}
==========

In this systematic review of epidemiological studies, no clear relationship was found between parental smoking and the risk of CBT. Similar results were obtained in dose-response analysis and stratified analysis. Although some of the summary RRs (maternal smoking before pregnancy and paternal smoking before pregnancy) were borderline significant, the magnitudes of these associations were quite modest and within the range in which various sources of bias could explain them. Our findings were based on a total of 17 studies (including over 5,000 cancer cases) without obvious heterogeneity and publication bias. However, limited data were available for certain subgroups (e.g., cohort studies, studies conducted in Asia). Therefore, these results should be interpreted with caution.

Low to moderate between-study heterogeneity was observed for several pooled RRs and subgroup results. For example, low between-study heterogeneity was observed (I^2^ = 28.2%, 95% CI 1.6%-60.7%) for maternal smoking during pregnancy, which was not surprising given the differences in study design, characteristics of populations, histological subtypes, and adjustment for confounding factors. Influence analysis suggested that after omitting some specific studies, the pooled RRs of remaining studies became significant, which indicated that some combined RRs of this meta-analysis were not very steady. For example, the omission of the study conducted by Brooks et al [@pone.0102910-Brooks1] led to a significant inverse association between maternal smoking during pregnancy and CBT risk. This may be because Brooks et al\'s study is a prospective cohort study, which included large samples (1,441,942 Swedish births) and reported a significant positive association between maternal smoking during pregnancy and CBT risk [@pone.0102910-Brooks1].

Currently, a variety of genetic syndromes, including NF1, NF2, TSC1, TSC2, and VHL, have been causally linked to CBT [@pone.0102910-Pollack1]. However, the environmental risk factors of brain tumors have not been fully established. The only recognized factor is exposure to ionizing radiation, which has been widely reported as significantly increasing the risk of CBT [@pone.0102910-Vinchon1], [@pone.0102910-Baldwin1]. Other environmental factors, such as cured meats, certain viruses (e.g., JC virus, SV40, etc.), parental heat exposure before pregnancy and fertility treatment, have shown inconsistent associations with CBT [@pone.0102910-Baldwin1]-[@pone.0102910-Hargreave1]. Although the relationship between parental smoking and CBT risk is biologically plausible, the epidemiological data are complex. Meta-analysis is a useful tool for revealing trends that might not be apparent in individual studies. Using this method, our study doesn\'t support that parental smoking is an environmental risk factor of CBT.

The largest number of available studies on a specific type of parental smoking was for maternal smoking during pregnancy (n = 16). Consistent with a previous meta-analysis published in 2002 [@pone.0102910-Huncharek1], our meta-analysis also found no association between maternal smoking during pregnancy and the risk of CBT. Previous studies have reported that maternal smoking during pregnancy is a possible risk factor for stillbirth [@pone.0102910-Flenady1], child overweight [@pone.0102910-Oken1] and childhood NHL [@pone.0102910-Antonopoulos1] but not for childhood HL [@pone.0102910-Antonopoulos1], leukemia [@pone.0102910-Klimentopoulou1] or testicular cancer [@pone.0102910-Tuomisto1]. Therefore, maternal smoking may have different effects on offspring through multiple mechanisms, specific and non-specific.

Our meta-analysis also explored the relationship between paternal smoking before and during pregnancy and the risk of CBT. A relationship between paternal smoking and CBT risk is biologically plausible. Linschooten et al reported that paternal smoking could affect the chance of heritable mutations in unstable repetitive DNA sequences [@pone.0102910-Linschooten1]. The study of Laubenthal et al also supported that cigarette smoke was a human germ cell mutagen [@pone.0102910-Laubenthal1]. Additionally, paternal smoking may play a role through the mother\'s passive exposure to secondhand smoke during pregnancy. Previous studies found that certain compounds in environmental tobacco smoke may pass through the placental barrier and interact with fetal DNA, resulting in DNA damage and mutation [@pone.0102910-Rice1], [@pone.0102910-Tredaniel1]. However, the epidemiological evidence on this topic is very controversial. Our meta-analysis, including all the published studies, doesn\'t support a link between paternal smoking before and during pregnancy and the risk of CBT.

Overall, our meta-analysis did not support the relationship between parental smoking and the risk of CBT, regardless of the source of parental exposure. These similar results between maternal and paternal smoking before and during pregnancy were consistent with the findings of Milne et al, Hu et al, and Gold et al [@pone.0102910-Milne1], [@pone.0102910-Hu1], [@pone.0102910-Gold1], who also investigated all four types of parental smoking. Clearly identifying and classifying the source of smoke exposure may help conduct unbiased assessments of parental smoking, which will help strengthen the conclusion and provide a comprehensive evaluation.

Our study has several strengths. Our meta-analysis of 17 studies involving a large number of cases and participants enhanced the statistical power to detect potential associations and provided more reliable estimates. A dose-response relationship between parental smoking and the risk of CBT was investigated, which further strengthened the conclusion. Half of the included studies considered several subtypes of CBT, allowing us to conduct separate analyses for these cancer subtypes. The absence of important heterogeneity and publication bias supported the robustness of the study findings.

However, several limitations of our meta-analysis should also be acknowledged. First, in this meta-analysis, the vast majority of the included studies were case-control studies. As mentioned previously, recall bias and selection bias might cause a decrease in quality of smoking exposure data. Mothers of children with CBT may be more reluctant to report harmful events during pregnancy than mothers of healthy children [@pone.0102910-Florescu1]. Therefore, this misclassification may lead to biased or spurious results. In recent years, several studies reported that cotinine measured in the dried blood spots was a reliable and accurate marker of maternal smoking close to the time of delivery [@pone.0102910-SearlesNielsen1]--[@pone.0102910-Yang1]. Therefore, this low-cost and objective method could be adapted in future relevant etiologic studies to overcome a moderate amount of exposure measurement error. Second, a meta-analysis is unable to solve problems with confounding factors that could be inherent in the included studies. Inadequate control of all known confounders can produce bias in either direction, toward exaggeration or underestimation of risk estimates [@pone.0102910-Larsson1]. Although we included the data from the most fully adjusted models, residual confounding cannot be completely excluded as a potential interpretation of the observed findings. Third, the results of this study were mainly based on information from western populations, while only two studies [@pone.0102910-Hu1], [@pone.0102910-Ji1] from other populations. Different races may have different genetic backgrounds that may affect CBT risk. Thus to generalize the findings, further study in other populations is warranted.

In conclusion, the results from this meta-analysis suggest that, based on available information, parental smoking is not associated with the risk of CBT. Because our meta-analysis has several limitations and the influence analysis suggests that some of the combined results are not very steady, future large well-designed prospective cohort studies with better exposure assessment are warranted to confirm the findings from our study and provide a higher level of evidence.
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**PRISMA checklist.**

(DOC)
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Click here for additional data file.
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**Forest plot of paternal smoking during pregnancy (A), maternal smoking before pregnancy (B), paternal smoking before pregnancy (C), and the risk of CBT.**

(TIF)
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Click here for additional data file.
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**Dose-response analysis of paternal smoking during pregnancy (A), maternal smoking before pregnancy (B), paternal smoking before pregnancy (C), and the risk of CBT.** The solid line represents point estimates of association between parental smoking and CBT risk; dashed lines are 95% CIs. Circles are the dose-specific RR estimates. The relative size of each circle is proportional to the inverse variance of the RR.

(TIF)
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Click here for additional data file.
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**Influence analysis of maternal smoking during pregnancy (A), paternal smoking during pregnancy (B), maternal smoking before pregnancy (C), paternal smoking before pregnancy (D), and the risk of CBT.**

(TIF)

###### 

Click here for additional data file.
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